Cartesian Therapeutics, Inc. (RNAC)

Cartesian Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts that cover Cartesian Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $34, which forecasts a 318.20% increase in the stock price over the next year. The lowest target is $16 and the highest is $44.

Price Target: $34 (+318.20%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$16	$34	$38	$44
Change	+96.80%	+318.20%	+367.40%	+441.21%

Analyst Ratings

The average analyst rating for Cartesian Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	4	4	4	4	3
Buy	1	1	1	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	6	6	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Martin Fan Wedbush	Wedbush	Buy Reiterates $38	Buy	Reiterates	$38	+367.40%	May 1, 2026
Martin Fan Wedbush	Wedbush	Buy Reiterates $38	Buy	Reiterates	$38	+367.40%	Mar 10, 2026
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Hold → Buy Upgrades $16	Hold → Buy	Upgrades	$16	+96.80%	Mar 9, 2026
Gil Blum Needham	Needham	Strong Buy Reiterates $42	Strong Buy	Reiterates	$42	+416.61%	Mar 9, 2026
Gil Blum Needham	Needham	Strong Buy Maintains $40 → $42	Strong Buy	Maintains	$40 → $42	+416.61%	Jan 9, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

13.33M

Increased by 376.58%

from 2.80M

Revenue Next Year

53.04K

Decreased by -99.60%

from 13.33M

EPS This Year

-3.70

from -5.02

EPS Next Year

-3.58

from -3.70

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	85.08M	110.78M	26.00M	38.91M	2.80M	13.33M	53.04K
Revenue Growth	-	30.21%	-76.53%	49.64%	-92.81%	376.58%	-99.60%
EPS	-6.74	2.98	-49.76	-4.48	-5.02	-3.70	-3.58
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	81.9M	327,600
Avg	13.3M	53,040
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	2,828.1%	-97.5%
Avg	376.6%	-99.6%
Low	-	-

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-3.02	-2.57
Avg	-3.70	-3.58
Low	-4.25	-4.31

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.